UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 13, 2020
Accession Number:
0001213900-20-000338
Submission Type:
POS AM
CIK:
0001611747
Company Name:
BiondVax Pharmaceuticals Ltd.
File Number:
333-201283